Arysta LifeScience and Delbon Sign Global Licensing Agreement
14 January 2013 
Arysta LifeScience Corporation has signed a global licensing agreement with France-based Delbon for Delsol, a soil biostimulant containing the microorganism Pseudomonas putida “fluorescent.”
The agreement also gives Arysta LifeScience first refusal right to other new biostimulant technology developed by Delbon and its scientific partners.
Benoit Genot, Head of Marketing, Global Biostimulants and Value-added Nutrients, told Farm Chemicals International in a recent interview that he believes that since 2000, biostimulants have been gaining momentum and credibility. “We strongly believe the future of this new market can be a solution to farmers,” he says.
Delsol is a proprietary product that was developed by Delbon and CIRAD-Montpellier in France. Delsol allows farmers to grow crops in difficult soil conditions by preserving beneficial microbial soil activity and optimizing the soil’s nutritional capacity. Arysta LifeScience intends to focus first on development of Delsol in the fruit and vegetable market.
“Microbial soil balance has often been neglected by modern agriculture,” says Genot. “The total biostimulant and value-added nutrient market is $2.5 billion, with average growth at 8%.
Delsol is presented in a liquid form so that it can be used easily with farmer’s existing sprayers and irrigation systems.
“Delbon has strong production assets and is looking to invest in new production capacity as product demand will increase. Arysta LifeScience is focused on field development, marketing and distribution of the product in key countries. This agreement is a good fit to maximize the market potential for Delsol,” says François Deleuze, CEO of Delbon.
Product evaluation of DELSOL will start in early 2013, and the first sales are expected in 2014.
Get The Newsletter Today!
